| Patents for A61K 9 - Medicinal preparations characterised by special physical form (299,044) |
|---|
| 08/12/2004 | WO2004056311A3 Stimuli-responsive systems for controlled drug delivery |
| 08/12/2004 | WO2004054638A3 Dermal, transdermal, mucosal or transmucosal ingredient delivery devices |
| 08/12/2004 | WO2004052334A3 Drug delivery particles and methods of treating particles to improve their drug delivery capabilities |
| 08/12/2004 | WO2004052287A3 Topical composition for heightened sensitivity |
| 08/12/2004 | WO2004050019A3 Method and compositions for treating anxiety |
| 08/12/2004 | WO2004047800A3 Method of drug loading in liposomes by gradient |
| 08/12/2004 | WO2004047792A3 Liposomal glucocorticoids |
| 08/12/2004 | WO2004047718A3 Process for manufacturing sustained release microbeads containing venlafaxine hci |
| 08/12/2004 | WO2004043363A3 Protein-stabilized liposomal formulations of pharmaceutical agents |
| 08/12/2004 | WO2004041206A3 Waxy matrix dosage forms |
| 08/12/2004 | WO2004037262A3 Immediate release topical pharmaceutical formulation for enhancement of female sexual desire and responsiveness |
| 08/12/2004 | WO2004033662A3 Optimizing giant unilamellar vesicle (guv) growth in a physiological buffer and artificial cell based biosensor |
| 08/12/2004 | WO2004032789A3 Liposomal hgh composition and method for administration thereof |
| 08/12/2004 | WO2004026231A3 Formulation for lipophilic agents |
| 08/12/2004 | WO2004022032A3 Pharmaceutical dosage form comprising a sulfite compound |
| 08/12/2004 | WO2004021972A3 Pharmaceuticals formulations and methods for modified release of statin drugs |
| 08/12/2004 | WO2004019867A3 Breath freshening and oral cleansing product using cardamom oil |
| 08/12/2004 | WO2004012664A3 Administration of estradiol metabolites for inhibition of drug-induced nephrotoxicity |
| 08/12/2004 | WO2004009664A3 Biodegradable triblock copolymers, synthesis methods therefor, and hydrogels and biomaterials made there from |
| 08/12/2004 | WO2004002999A3 Modified 2' and 3' -nucleoside produgs for treating flaviridae infections |
| 08/12/2004 | WO2004002551A3 Inhalable epinephrine |
| 08/12/2004 | WO2003105611A9 Beverages containing plant sterols |
| 08/12/2004 | WO2003099214A3 Biguanide formulations |
| 08/12/2004 | WO2003086297A3 Multi-layer mucoadhesive drug delivery device with bursting release layer |
| 08/12/2004 | WO2003057133A9 Herbal composition for treating various disorders including psoriasis, a process for preparation thereof and method for treatment of such disorders |
| 08/12/2004 | US20040158232 Implantable artificial pancreas |
| 08/12/2004 | US20040158038 Pullan-trehalose fusion which enhances functionality of seasonings, spices, colorings, flavorings, emulsifiers and plasticizers |
| 08/12/2004 | US20040157953 Materials for filling cavities in the body |
| 08/12/2004 | US20040157951 Monodisperse preparations useful with implanted devices |
| 08/12/2004 | US20040157936 Anhydrous topical skin preparations |
| 08/12/2004 | US20040157928 Controlled disintegration ; concentration; bioavailability; mixture containing surfactant, water and polyoxyethylene glycol; adjust solubility |
| 08/12/2004 | US20040157925 Stable pharmaceutical composition of pravastatin |
| 08/12/2004 | US20040157911 Storage-stable and bio-stable formulations of ace inhibitors, and methods for preparation thereof |
| 08/12/2004 | US20040157908 (-)-1-(3,4-dichlorophenyl)-3-azabicyclo[3.1.0]hexane, compositions thereof, and uses as a dopamine-reuptake inhibitor |
| 08/12/2004 | US20040157895 Compositions and methods for lowering plasma lipoprotein(a) and risk factors of cardiovascular diseases |
| 08/12/2004 | US20040157887 Antisecretory agents; gastrointestinal agents |
| 08/12/2004 | US20040157884 Accurate, long duration, controlled release of opioids at small dosage levels; implants; minimizing tissue trauma |
| 08/12/2004 | US20040157876 Solid dosage forms; melt granulation |
| 08/12/2004 | US20040157870 for treating or preventing attention-deficit disorder, depression, obesity, Parkinson's disease, a tic disorder, or an addictive disorder |
| 08/12/2004 | US20040157869 (-)-1-(3,4-dichlorophenyl)-3-azabicyclo[3.1.0]hexane, compositions thereof, and uses as a dopamine-reuptake inhibitor |
| 08/12/2004 | US20040157840 Rifalazil compositions and therapeutic regimens |
| 08/12/2004 | US20040157825 Quinolone carboxylic acid compositions and related methods of treatment |
| 08/12/2004 | US20040157815 fluticasone propionate is completely dissolved in a hydrofluoroalkane (HFA) propellant for use in metered dose inhalers |
| 08/12/2004 | US20040157797 poorly water soluble active agent with solubilizing agent crystalline methylated beta -cyclodextrin; active agent is carbamazepine, fenofibrate, oxcarbazepine, or glipizide |
| 08/12/2004 | US20040157796 Concentrated liquid valdecoxib composition |
| 08/12/2004 | US20040157791 Systemic immune activation method using nucleic acid-lipid complexes |
| 08/12/2004 | US20040157789 mixing a block copolymer with a population of polynucleotide molecules, a cationic surfactant, and an amorphous cryoprotectant or a bulking agent |
| 08/12/2004 | US20040157777 peptides that bind to the Y2 receptor when administered peripherally to a mammal induce weight loss |
| 08/12/2004 | US20040157769 Stabilized pharmaceutical composition in lyophilized form |
| 08/12/2004 | US20040157766 Topical pharmaceutical and/or cosmetic dispense systems |
| 08/12/2004 | US20040157207 Hyperbranched amylopectin for use in methods for surgical or therapeutic treatment of mammals or in diagnostic methods expecially for use as a plasma volume expander |
| 08/12/2004 | US20040157073 Lubricious coatings for substrates |
| 08/12/2004 | US20040156993 a coating liquid for preperation of a hard coating layer for food or medicine containing any one of sugar/sugar alcohols selected from maltitol, xylitol, erythritol, mannitol, lactitol, trehalose, sucrose, and oxidized starch |
| 08/12/2004 | US20040156930 A dissolving patch containing antibiotics (penicillin, amoxicillin) or other medicants (amlexanox and licorice (glycyrrhiza) extract) to treat canker sores of the mouth through sustained release of the healing agents |
| 08/12/2004 | US20040156928 label adhered to clothing worn close to the body with a thinning agent, which is released from the label to the surrounding environment of the clothing wearer and enters into the natural body openings of the upper airways |
| 08/12/2004 | US20040156915 releasing a mixture of blood-dispersible gas and aqueous sclerosant liquid in a container, to effect interaction of the components to form a microfoam; used to eliminate varicose veins and other disorders involving venous malformation |
| 08/12/2004 | US20040156914 Slow release protein polymers |
| 08/12/2004 | US20040156913 poly(alpha-hydroxy acid), a polyhydroxy butyric acid, a polycaprolactone, a polyorthoester, a polyanhydride, or a polycyanoacrylate, formed using detergents; biologically active macromolecule adsorbed on surface |
| 08/12/2004 | US20040156912 Surface functional member (member provided with surface layer of adsorbed functional particles) |
| 08/12/2004 | US20040156910 Phytochemicals for treatment of mastalgia and endometriosis |
| 08/12/2004 | US20040156909 especially amphiphilic cationic or anionic vinyl ether polymers (e.g., copolymerized with maleic anhydride) electrostatically or covalently attached to the polynucleotide |
| 08/12/2004 | US20040156907 Pharmaceutical compositions using semi-solid delivery vehicle |
| 08/12/2004 | US20040156906 Thermosensitive and biodegradable microgel and a method for the preparation thereof |
| 08/12/2004 | US20040156905 Pharmaceutical compositions of semi-ordered drugs and polymers |
| 08/12/2004 | US20040156904 matrix of PEG-g-chitosan and water insoluble polylactic acid, poly-lactide glycolide, polycaprolactones, EVA, or polyanhydridie used as a delivery vehicle for pharmaceuticals and biomedical materials. |
| 08/12/2004 | US20040156903 Metering and packaging of controlled release medication |
| 08/12/2004 | US20040156902 interior surface of the first portion has cavities with indentations and a second molded thermoplastic portion is inlaid into the cavities and resides conformally upon the indentations; filled-in intagliations with raised or flush fill |
| 08/12/2004 | US20040156901 Pharmaceutical composition of topiramate |
| 08/12/2004 | US20040156900 core of an active agent and a swelling agent, and a coating of film forming polymer, which swells when it imbibes fluid from the core and ruptures to release the drug in a pulse in a reliable manner |
| 08/12/2004 | US20040156899 Formulation of an erodible, gastric retentive oral dosage form using in vitro disintegration test data |
| 08/12/2004 | US20040156898 minimizes the variation between peak and trough plasma levels of valproate over a 24 hour dosing period. This formulation follows a zero-order release pattern thus producing essentially flat plasma levels of valproate, once steady-state levels have |
| 08/12/2004 | US20040156897 in association with a polymer; produces a Cmax that is statistically significantly lower than the Cmax produced by a delayed release divalproex sodium tablet; minimnizes the variation between peak and trough plasma levels over a 24 hour period |
| 08/12/2004 | US20040156896 Oral controlled release dosage form |
| 08/12/2004 | US20040156895 Solid dosage forms comprising pullulan |
| 08/12/2004 | US20040156894 such as citric acid, maleic acid, tartaric acid or hydrochloric acid; reduces disintegration time for water insoluble, solid, lyophilized, oral pharmaceutical dosage forms |
| 08/12/2004 | US20040156893 Method for treating hypothyroidism |
| 08/12/2004 | US20040156892 Soft shell gelatin capsules containing non-steroidal anti-inflammatories |
| 08/12/2004 | US20040156891 gradient loading procedure, at a pH that prevents precipitation of the drug from the loading solution; preparing giant multivesicular liposomes with high drug-to-lipid ratios; provide long term analgesia. |
| 08/12/2004 | US20040156890 Polycationic sterol derivatives as transfection agents |
| 08/12/2004 | US20040156889 transmembrane pH gradient; protonated form of the drug not capable of permeating liposome membrane, unprotonated form can penetrate; product has a lower inside/higher outside pH gradient and preferably a high drug:lipid ratio |
| 08/12/2004 | US20040156888 lipophobic drug encapsulated in a liposome; elimination half-life of the therapeutic agent when administered as part of the formulation is less than about 14 hours in a rat. |
| 08/12/2004 | US20040156887 Stabilized dispersion of phytosterol in oil |
| 08/12/2004 | US20040156886 tension shear adhesive strength when the adhesive agent surface is overlappingly adhered on the support surface is 0.015 to 0.07 kgf/cm2; overlapped portion does not curl up and immediately peel off |
| 08/12/2004 | US20040156885 Water soluble film for oral administration with instant wettability |
| 08/12/2004 | US20040156874 Urea- a topical anti-inflammatory |
| 08/12/2004 | US20040156872 nanoparticulates have an effective average particle size of less than about 2000 nm; and a surface stabilizer adsorbed on or associated with the surface |
| 08/12/2004 | US20040156871 hydrophilic/hydrophobic solubilizer such as polyoxyethanyl-sitosterol sebacate, polyoxyethanyl-cholesteryl sebacate or polyoxyethanyl- alpha-tocopheryl sebacate with a polyene macrolide antibiotic or a polyunsaturated fatty acid oil |
| 08/12/2004 | US20040156867 Proteosome influenza vaccine |
| 08/12/2004 | US20040156859 GP-41 peptides, BBB peptides, anticancer agents, antihistamines, bronchodilators, hypotensive agents, antiangina agents, opioids, analgesics, antidepressants, and hypothyroid agents reactive with amino, hydroxyl or thiol groups |
| 08/12/2004 | US20040156840 A preferred IgM is autoantigen IgM, in particular anti-ds-DNA and anti-phospholipid IgM; may be mixed with an antiinflammatory agent, an immunosuppressive agent and/or a cytostatic agent |
| 08/12/2004 | US20040156836 combination of coenzyme Q and a surfactant can prevent ascites even when administering in a small dose and within a short period of time |
| 08/12/2004 | US20040156794 Bioerodible and bioadhesive confectionery products and methods of making same |
| 08/12/2004 | US20040156793 Skin care composition and method of skin treatment |
| 08/12/2004 | US20040156792 Pharmaceutical formulation with an insoluble active agent |
| 08/12/2004 | US20040156791 Heating antipsychotic drug to vaporize; cooling to form condensation aerosol; kit for dispensing thin coating |
| 08/12/2004 | US20040156790 Delivery of drug esters through an inhalation route |
| 08/12/2004 | US20040156789 Delivery of antihistamines through an inhalation route |
| 08/12/2004 | US20040156788 Delivery of erectile dysfunction drugs through an inhalation route |
| 08/12/2004 | US20040156781 Polymeric materials for site specific delivery to the body |
| 08/12/2004 | US20040154985 Method and apparatus for producing particles via supercritical fluid processing |